These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8195032)

  • 1. The role of specific reductases in the intracellular activation and binding of 2-nitroimidazoles.
    Joseph P; Jaiswal AK; Stobbe CC; Chapman JD
    Int J Radiat Oncol Biol Phys; 1994 May; 29(2):351-5. PubMed ID: 8195032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NAD(P)H:quinone oxidoreductase1 (DT diaphorase) specifically prevents the formation of benzo[a]pyrene quinone-DNA adducts generated by cytochrome P4501A1 and P450 reductase.
    Joseph P; Jaiswal AK
    Proc Natl Acad Sci U S A; 1994 Aug; 91(18):8413-7. PubMed ID: 8078896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of misonidazole by rat liver microsomes and purified NADPH-cytochrome c reductase.
    McManus ME; Lang MA; Stuart K; Strong J
    Biochem Pharmacol; 1982 Feb; 31(4):547-52. PubMed ID: 6802140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase.
    Fourie J; Oleschuk CJ; Guziec F; Guziec L; Fiterman DJ; Monterrosa C; Begleiter A
    Cancer Chemother Pharmacol; 2002 Feb; 49(2):101-10. PubMed ID: 11862423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DT-diaphorase protects cells from the hypoxic cytotoxicity of indoloquinone EO9.
    Plumb JA; Gerritsen M; Workman P
    Br J Cancer; 1994 Dec; 70(6):1136-43. PubMed ID: 7526885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of NADPH:cytochrome c reductase and DT-diaphorase in the biotransformation of mitomycin C1.
    Keyes SR; Fracasso PM; Heimbrook DC; Rockwell S; Sligar SG; Sartorelli AC
    Cancer Res; 1984 Dec; 44(12 Pt 1):5638-43. PubMed ID: 6437671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reductive metabolism of the nitroimidazole-based hypoxia-selective cytotoxin NLCQ-1 (NSC 709257).
    Papadopoulou MV; Ji M; Rao MK; Bloomer WD
    Oncol Res; 2003; 14(1):21-9. PubMed ID: 14552588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NAD(P)H:quinone oxidoreductase 1 reduces the mutagenicity of DNA caused by NADPH:P450 reductase-activated metabolites of benzo(a)pyrene quinones.
    Joseph P; Jaiswal AK
    Br J Cancer; 1998 Mar; 77(5):709-19. PubMed ID: 9514048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reductase enzyme expression across the National Cancer Institute Tumor cell line panel: correlation with sensitivity to mitomycin C and EO9.
    Fitzsimmons SA; Workman P; Grever M; Paull K; Camalier R; Lewis AD
    J Natl Cancer Inst; 1996 Mar; 88(5):259-69. PubMed ID: 8614004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioreductive metabolism of the novel fluorinated 2-nitroimidazole hypoxia probe N-(2-hydroxy-3,3,3-trifluoropropyl)-2-(2-nitroimidazolyl) acetamide (SR-4554).
    Aboagye EO; Lewis AD; Tracy M; Workman P
    Biochem Pharmacol; 1997 Dec; 54(11):1217-24. PubMed ID: 9416972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of the metabolism-induced binding of misonidazole to hypoxic mammalian cells.
    Chapman JD; Baer K; Lee J
    Cancer Res; 1983 Apr; 43(4):1523-8. PubMed ID: 6831401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the xanthine oxidase inhibitor allopurinol on the renal clearance of nitroimidazoles.
    Workman P; White RA
    Biochem Pharmacol; 1982 Oct; 31(19):3041-6. PubMed ID: 6897355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of human NADPH:cytochrome c (P450) reductase confers enhanced sensitivity to both tirapazamine (SR 4233) and RSU 1069.
    Patterson AV; Saunders MP; Chinje EC; Talbot DC; Harris AL; Strafford IJ
    Br J Cancer; 1997; 76(10):1338-47. PubMed ID: 9374381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative importance of DT-diaphorase and hypoxia in the bioactivation of EO9 by human lung tumor cell lines.
    Plumb JA; Gerritsen M; Milroy R; Thomson P; Workman P
    Int J Radiat Oncol Biol Phys; 1994 May; 29(2):295-9. PubMed ID: 8195022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of NADPH:cytochrome P450 reductase in the hypoxic accumulation and metabolism of BRU59-21, a technetium-99m-nitroimidazole for imaging tumor hypoxia.
    Melo T; Ballinger JR; Rauth AM
    Biochem Pharmacol; 2000 Sep; 60(5):625-34. PubMed ID: 10927020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-enzymatic and enzymatic activation of mitomycin C: identification of a unique cytosolic activity.
    Joseph P; Xu Y; Jaiswal AK
    Int J Cancer; 1996 Jan; 65(2):263-71. PubMed ID: 8567127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioreductive metabolism of AF-2[2-(2-furyl)-3-(5-nitro-2-furyl)acrylamide] combined with 2-nitroimidazoles. Implications for use as hypoxic cell markers.
    Koch CJ; Giandomenico AR; Iyengar CW
    Biochem Pharmacol; 1993 Sep; 46(6):1029-36. PubMed ID: 8216345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism induced binding of 14C-misonidazole to hypoxic cells: kinetic dependence on oxygen concentration and misonidazole concentration.
    Koch CJ; Stobbe CC; Baer KA
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1327-31. PubMed ID: 6469755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of DT-diaphorase (NAD(P)H:quinone oxidoreductase, EC 1.6.99.2) by 5,6-dimethylxanthenone-4-acetic acid (DMXAA) and flavone-8-acetic acid (FAA): implications for bioreductive drug development.
    Phillips RM
    Biochem Pharmacol; 1999 Jul; 58(2):303-10. PubMed ID: 10423172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [DT-diaphorase].
    Mikami K; Shirakusa T; Tsuruo T
    Gan To Kagaku Ryoho; 1997 Sep; 24(11):1606-10. PubMed ID: 9309161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.